Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;45(2):193-7.
doi: 10.1097/MPA.0000000000000376.

Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression

Brian P Riff  1 , David A Leiman, Bonita Bennett, Douglas L Fraker, David C Metz
Affiliations

Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression

Brian P Riff et al. Pancreas. 2016 Feb.

Abstract

Objectives: Zollinger-Ellison syndrome (ZES) is characterized by hypergastrinemia and gastric acid hypersecretion resulting in peptic ulcer disease, diarrhea, and weight loss. Acid secretion can be controlled with medication, and biochemical cure is possible with surgery. Data on how these interventions affect patients' weight are lacking. We aimed to determine how medical and surgical acid control affects weight over time.

Methods: We performed a retrospective cohort study on 60 ZES patients. Acid control was achieved with appropriate-dose proton pump inhibitor (PPI) therapy. Surgery was performed for curative intent when appropriate. Weight change was assessed versus pre-acid control or immediate preoperative weights and expressed as absolute and percent change from baseline at 6, 12, 18, and 24 months.

Results: A total of 30 PPI-controlled patients and 20 surgery-controlled patients were analyzed. Weight gain was noted at all time points while on appropriate-dose PPI therapy (P < 0.005). Of patients who had surgery with curative intent, weight gain was noted at 12 months (7.9%, P = 0.013) and 18 months (7.1%, P = 0.007). There was a trend toward weight gain seen at all time points in the patients who were surgically cured.

Conclusions: These data represent a novel description of weight gain after acid suppression in ZES.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of Study Subjects
Figure 2
Figure 2
Percent change in weight over time from baseline in medical acid controlled (MAC) group.
Figure 3
Figure 3
Percent change in weight over time from baseline in surgical acid controlled (SAC) group divided by biochemical cure status
See this image and copyright information in PMC

References

    1. Osefo N, Ito T, Jensen RT. Gastric acid hypersecretory states: recent insights and advances. Curr Gastroenterol Rep. 2009;11:433–441. - PMC - PubMed
    1. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955;142:709–728. - PMC - PubMed
    1. Ellison EH, Wilson SD. The Zollinger-Ellison Syndrome: Re-Appraisal and Evaluation of 260 Registered Cases. Ann Surg. 1964;160:512–530. - PMC - PubMed
    1. Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine. 2000;79:379–411. - PubMed
    1. Wilcox CM, Seay T, Arcury JT, et al. Zollinger–Ellison syndrome: Presentation, response to therapy, and outcome. Digestive and Liver Disease. 2011;43:439–443. - PubMed

Publication types

Substances